Navigation Links
Anavex reports animal study results as lead Alzheimer's compound approaches phase 1 clinical trials

nts if development proves successful," said Dr. Durrant. "Currently available therapies primarily treat the symptoms, as opposed to modifying the disease, and can fade in terms of effectiveness over time. Several experimental therapies being developed will have to be administered as injections or intravenous infusions. ANAVEX 2-73, and the follow-on compounds the company has in its pipeline, may prove to be novel disease-modifying agents that could impact the natural history of Alzheimer's disease, and which may be administered orally."

About Anavex Life Sciences Corp.

Anavex Life Sciences Corp. ( is a publicly traded biopharmaceutical company engaged in the discovery and development of novel drug candidates for the treatment of neurological diseases such as Alzheimer's, epilepsy, depression and pain, as well as cancer. The company's proprietary SIGMACEPTOR(TM) Discovery Platform involves the rational design of drug compounds that fulfill specific criteria to target specific receptors involved in the modulation of multiple cellular biochemical signaling pathways.

ANAVEX's SIGMACEPTOR(TM)-N program involves the development of novel and original drug candidates that target neurological and neurodegenerative diseases (Alzheimer's disease, epilepsy, depression, pain). The company's lead drug candidates exhibit high, non-exclusive affinity for sigma receptors, which have been extensively documented as potentially valuable drug targets and have demonstrated evidence for anti-amnesic and neuroprotective properties. The company is developing non-amyloid focused approaches to disease modification in Alzheimer's disease. ANAVEX 2-73 and the company's severa

SOURCE Anavex Life Sciences Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Anavex comments on failure of Pfizer and Medivations Alzheimers investigational drug Dimebon during Phase 3 clinical trials
2. Anavex appoints Dr. Dimitri Goundis to lead Clinical Development
3. Anavex 7-1037 reduces rate of cancer tumor growth 69% in pre-clinical studies, compared to currently marketed drug Dacarbazine showing no measurable activity
4. Anavex strengthens Board of Directors
5. Anavex advances drug candidate for treatment of Alzheimers disease
6. PharmAthene Reports Year-End 2009 Financial and Operational Results and Provides Update On Ongoing Litigation With SIGA Technologies
7. Champions Biotechnology Reports Fiscal 2010 Third Quarter Financial Results
8. Viron reports positive proof of concept results in arthritis for its VT-346 anti-TNF therapeutic
9. BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results
10. American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results
11. The Cancer Market Outlook To 2014: Competitive Landscape, Market Size, Pipeline Analysis and Growth Opportunities Now Available on ReportsandReports
Post Your Comments:
(Date:10/1/2015)...  xG Health Solutions, a leading healthcare management ... platform for communication and collaboration with healthcare organizations. ... health plans improve the quality and efficiency of ... products and educational resources. "Our ... we know the process of re-engineering care delivery ...
(Date:10/1/2015)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... Aegis Growth Conference, taking place October 7-9, 2015 in ... of Oramed, will present a corporate overview on October ... 2015 Aegis Growth Conference Date: Thursday, October ...
(Date:10/1/2015)... ... ... Hearth in Potsdam, NY. and a member of the Masonry Heater Association of North ... northern New York. The masonry heater fireplace is beautiful, simple, and it burns a fraction ... the home comfortable but when it is below zero, their needs to be one fire ...
(Date:9/30/2015)... /PRNewswire/ - Resverlogix Corp. (the "Corporation") (TSX:RVX) today announced that, ... September 30, 2015, each of the five nominees proposed as ... August 17, 2015 were elected as directors.  Proxy voting results ... Withheld , % For , % WithheldDonald J. McCaffrey , ... , 0.40% Peter Johann , 32,990,226 ...
Breaking Biology Technology:xG Health Solutions Launches New Platform for Hospitals, Clinics and Health Plans 2Oramed to Present at the Aegis Capital Growth Conference 2Oramed to Present at the Aegis Capital Growth Conference 3The Masonry Heater Association of North America Receives News About A New York Couple Who Saved Considerable Money Heating Their Home With A Wood Fired Masonry Heater 2Resverlogix Announces Voting Results 2
... growth company of diversified businesses, ... Transportation Accessories Group has acquired ... zinc plating services. Chem-Chrome is ... has been a longtime processor ...
... Software, worldwide leader in e-document ... Fax and VSI-FAX(R) product families, ... 3.0. This new solution allows ... more efficiently, effectively, and economically ...
... nanoscale device developed by a University of Wisconsin-Madison Engineering ... electrons in such devices as laptop computers and provide ... This device will allow researchers to study ... heat dissipation on single electron transport in transistors. ...
Cached Biology Technology:Cool Computers 2Cool Computers 3
(Date:9/10/2015)... , Sept. 10, 2015 Report ... New Study Reveals Selling Opportunities and Revenue Prospects ... the future of biologics, especially new drug classes? ... will stay ahead with exclusive market data and ... explore trends, developments, results, opportunities and sales predictions. ...
(Date:9/9/2015)... VANCOUVER, British Columbia , Sept. 9, 2015 ... achieved numerous organizational and solution-based milestones, furthering the ... the perils of online fraud. NuData ... key in enhancing the company,s growth cycle. The ... machine learning to determine good user behavior from ...
(Date:9/2/2015)... , Sept. 2, 2015 Security ... concern for enterprises, banks, government organizations, telecommunications, hospitals, ... numeric keypads were previously being used to prevent ... of two-factor authentication, wherein individuals could gain access ... different components, such as hardware devices and numeric ...
Breaking Biology News(10 mins):Next-Generation Biologics: R&D, Industry and Market Forecasts 2015-2025 2Next-Generation Biologics: R&D, Industry and Market Forecasts 2015-2025 3Next-Generation Biologics: R&D, Industry and Market Forecasts 2015-2025 4Next-Generation Biologics: R&D, Industry and Market Forecasts 2015-2025 5Next-Generation Biologics: R&D, Industry and Market Forecasts 2015-2025 6NuData Security Achieves Significant Milestones, Furthers Commitment to Providing Unparalleled Online Fraud Detection 2Global Biometrics Spending Market in the Government Sector 2015-2019 2Global Biometrics Spending Market in the Government Sector 2015-2019 3
... in India has risen in response to a 20-fold drop ... article in the Nov. 15 issue of Clinical Infectious Diseases, ... country has encouraged people to seek HIV treatment because of ... more than 5 million HIV-infected people living in India have ...
... people with compromised immune systems may be feasible ... who demonstrated their approach could protect against pneumocystis ... immune cells that HIV destroys in humans. The ... researchers, working in collaboration with researchers from the ...
... Researchers from Johns Hopkins have discovered the presence of ... These ion channels act like electrical wires and permit ... become all cell types of the body, to conduct ... selectively block some of these channels in implanted cells, ...
Cached Biology News:HIV mortality in India drops with introduction of generic antiretroviral therapy 2New vaccine platform may fight infections with causes from influenza to bioterrorism 2New vaccine platform may fight infections with causes from influenza to bioterrorism 3Stem cells' electric abilities might help their safe clinical use 2